Lazard Asset Management LLC Novavax Inc Transaction History
Lazard Asset Management LLC
- $63.4 Billion
- Q2 2025
A detailed history of Lazard Asset Management LLC transactions in Novavax Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 28,632 shares of NVAX stock, worth $251,675. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,632
Previous 20,840
37.39%
Holding current value
$251,675
Previous $133,000
35.34%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding NVAX
# of Institutions
309Shares Held
94.3MCall Options Held
6.11MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$136 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$104 Million0.0% of portfolio
-
Shah Capital Management11.5MShares$101 Million35.13% of portfolio
-
State Street Corp Boston, MA6.82MShares$60 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.94MShares$34.6 Million0.02% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $688M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...